Gotham Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Gotham Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-39,830	Closed	-$470K	–	1125
2017 Q3	$470K	Sell	39,830 -46,137	-54%	-$518K	0.01%	712
2017 Q2	$903K	Sell	85,967 -133,949	-61%	-$1.37M	0.01%	651
2017 Q1	$2.42M	Buy	219,916 +164,408	+296%	+$1.91M	0.03%	523
2016 Q4	$752K	Buy	+55,508	New	+$774K	0.01%	671
2016 Q2	–	Sell	-284,704	Closed	-$3.11M	–	1161
2016 Q1	$3.11M	Sell	284,704 -299,012	-51%	-$3.78M	0.03%	513
2015 Q4	$10.1M	Buy	583,716 +427,511	+274%	+$7.66M	0.11%	286
2015 Q3	$3.1M	Sell	156,205 -178,141	-53%	-$4.08M	0.03%	487
2015 Q2	$5.49M	Buy	334,346 +230,808	+223%	+$4M	0.05%	435
2015 Q1	$1.61M	Buy	+103,538	New	+$1.61M	0.01%	542

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Gotham Asset Management's SCMP Position: Q4 2017 in Review

Gotham Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 39,830 shares — an estimated $470K sold.

Gotham Asset Management first reported a position in SCMP in Q1 2015 and held it in 9 quarters. The position peaked at $10.1M in Q4 2015. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

Gotham Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Gotham Asset Management sold 39,830 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $470K.
Gotham Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 9 quarters.
Gotham Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $10.1M in Q4 2015.
188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Gotham Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.